000			03342nam a22003975c 4500
001			76571
003			ES-MaUEC
005			20230202102130.0
007			cr nn 008mamaa
008			140901s2014 gw | s |||| 0|eng d
020			_a9783662438367
024	7		_a10.1007/978-3-662-43836-7 _2doi
050		4	_aTP248.2 _b.C66 2014 EB
082	0	4	_a631.52
082	0	4	_a660.6
245	0	0	_aCommercial Plant-Produced Recombinant Protein Products : _bCase Studies _cedited by John A. Howard, Elizabeth E. Hood
260			_aBerlin, Heidelberg _bSpringer International Publishing _c2014
300			_a1 recurso en línea (XII, 281 p.) _b33 ilustraciones, 17 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aBiotechnology in Agriculture and Forestry _x0934-943X _v68
505	0		_aIntroduction ? Plant-produced protein products -- Commercial Plant-Produced Recombinant Avidin -- Molecular farming in plants ? the long road to the market -- TrypZeanTM: an animal-free alternative to bovine trypsin -- Production of Pharmaceutical Grade Recombinant Native Aprotinin and Non-Oxidized Aprotinin-Variants Under Greenhouse and Field Conditions -- Influenza virus-like particles produced in Nicotiana benthamiana protect against a lethal viral challenge in mice -- Plant-Produced Recombinant Transmission Blocking Vaccine Candidates to Combat Malaria -- An oral vaccine for TGEV immunization of pigs -- Edible Rabies Vaccines -- Newcastle disease vaccines -- An oral vaccine for hepatitis B: challenges, setbacks and breakthroughs -- Commercial Plant-Produced Recombinant Cellulases for Biomass Conversion -- Brazzein: A High Intensity Natural Sweetener -- The Future of Plant-Produced Pharmaceuticals and Industrial Proteins
520			_aAttention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the advantages that plants offer over bacterial, fungal or animal cell-culture hosts. There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically
942			_2lcc _cLE
988			_aEBOOK, EBSPRINGERrevisando
650		7	_aBiotecnología _0comprobar BNE19900991605 _2embne _9140931
700	1		_aHoward, John A. _eeditor literario _927567 _0comprobar BNE19984010296
700	1		_aHood, Elizabeth E. _eeditor literario _985707 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-662-43836-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783662438367
907			_a.b12821895 _b10-10-17 _c01-10-14
998			_am _a_alco _a_vill _b31-07-17 _cm _dz _eb _feng _ggw _h0
945			_aTP248.2 .C66 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11551100 _z06-04-17
999			_c76571 _d76571 _x1